CO5011050A1 - Tienopirimidinas - Google Patents

Tienopirimidinas

Info

Publication number
CO5011050A1
CO5011050A1 CO99025993A CO99025993A CO5011050A1 CO 5011050 A1 CO5011050 A1 CO 5011050A1 CO 99025993 A CO99025993 A CO 99025993A CO 99025993 A CO99025993 A CO 99025993A CO 5011050 A1 CO5011050 A1 CO 5011050A1
Authority
CO
Colombia
Prior art keywords
atoms
hal
groups
alkylene
represent
Prior art date
Application number
CO99025993A
Other languages
English (en)
Inventor
Jonas Rochus
Pierre Schelling
Kluxen Franz-Werner
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CO5011050A1 publication Critical patent/CO5011050A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compuestos de la fórmula Ien dondeR1 , R2 representan independientemente H, A, OA o Hal,R1 , R2 , juntos, también representan alquileno de 3 a 5 átomos de C, -O-CH2 -CH2 -, -CH2 -O-CH2 -, O-CH2 -O- u -O-CH2 -CH2 -O-,X representa R4 , R5 o R6 monosustituido con R7 ,R4 representa alquileno de cadena recta o ramificada y de 1 a 10 átomos de C, en el cual uno o dos grupos de CH2 pueden estar reemplazados por grupos -CH=CH-, R5 representa cicloalquilo o cicloalquilalquileno de 5 a 12 átomos de C,R6 representa fenilo o fenilmetilo, R7 representa COOH, COOA, CONH2 , CONHA, CON(A)2 o CN, A representa alquilo de 1 a 6 átomos de C yHal representa F,CI, Br o I,y sus sales aceptables desde el punto de vista fisiológico.
CO99025993A 1998-04-29 1999-04-29 Tienopirimidinas CO5011050A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19819023A DE19819023A1 (de) 1998-04-29 1998-04-29 Thienopyrimidine

Publications (1)

Publication Number Publication Date
CO5011050A1 true CO5011050A1 (es) 2001-02-28

Family

ID=7866082

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99025993A CO5011050A1 (es) 1998-04-29 1999-04-29 Tienopirimidinas

Country Status (27)

Country Link
US (1) US6495557B1 (es)
EP (1) EP1084125B1 (es)
JP (1) JP4242561B2 (es)
KR (1) KR20010042628A (es)
CN (1) CN1142936C (es)
AR (1) AR016233A1 (es)
AT (1) ATE314374T1 (es)
AU (1) AU743230B2 (es)
BR (1) BR9910032A (es)
CA (1) CA2328280C (es)
CO (1) CO5011050A1 (es)
CZ (1) CZ291109B6 (es)
DE (2) DE19819023A1 (es)
ES (1) ES2255754T3 (es)
HK (1) HK1037628A1 (es)
HU (1) HUP0101832A3 (es)
ID (1) ID27049A (es)
MY (1) MY121864A (es)
NO (1) NO20005434D0 (es)
PL (1) PL343637A1 (es)
RU (1) RU2224760C2 (es)
SK (1) SK15972000A3 (es)
TR (1) TR200003144T2 (es)
TW (1) TWI232220B (es)
UA (1) UA66856C2 (es)
WO (1) WO1999055708A1 (es)
ZA (1) ZA200006994B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928146A1 (de) * 1999-06-19 2000-12-21 Merck Patent Gmbh Thienopyrimidine
DE19943815A1 (de) * 1999-09-14 2001-03-15 Merck Patent Gmbh Verwendung von Thienopyrimidinen
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
WO2001051089A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
HUP0401368A2 (hu) * 2000-12-19 2004-10-28 Merck Patent Gmbh Tienopirimidineket és trombózisellenes szereket, kalcium antagonistákat, prosztaglandinokat vagy prosztaglandin származékokat tartalmazó gyógyszerkészítmények
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
US20040077664A1 (en) * 2001-01-31 2004-04-22 Hans-Michael Eggenweiler Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
WO2006023843A2 (en) * 2004-08-20 2006-03-02 Bayer Pharmaceuticals Corporation Novel heterocycles
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ME01609B (me) 2005-04-19 2014-09-20 Takeda Gmbh Roflumilast za liječenje pulmonarne hipertenzije

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
PH31122A (en) 1993-03-31 1998-02-23 Eisai Co Ltd Nitrogen-containing fused-heterocycle compounds.
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
DE69408750T2 (de) 1993-08-26 1998-07-23 Ono Pharmaceutical Co 4-Aminopyrimidin Derivate
US5869486A (en) 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19632423A1 (de) 1996-08-12 1998-02-19 Merck Patent Gmbh Thienopyrimidine
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
CZ291109B6 (cs) 2002-12-11
SK15972000A3 (sk) 2001-05-10
CA2328280A1 (en) 1999-11-04
HUP0101832A3 (en) 2002-11-28
CA2328280C (en) 2009-09-29
CZ20003976A3 (cs) 2001-02-14
BR9910032A (pt) 2001-10-16
AR016233A1 (es) 2001-06-20
WO1999055708A1 (de) 1999-11-04
CN1298406A (zh) 2001-06-06
ATE314374T1 (de) 2006-01-15
JP4242561B2 (ja) 2009-03-25
UA66856C2 (uk) 2004-06-15
HUP0101832A2 (hu) 2001-11-28
TWI232220B (en) 2005-05-11
EP1084125B1 (de) 2005-12-28
AU3709899A (en) 1999-11-16
PL343637A1 (en) 2001-08-27
JP2002513026A (ja) 2002-05-08
KR20010042628A (ko) 2001-05-25
ZA200006994B (en) 2002-05-28
TR200003144T2 (tr) 2001-03-21
EP1084125A1 (de) 2001-03-21
CN1142936C (zh) 2004-03-24
US6495557B1 (en) 2002-12-17
DE19819023A1 (de) 1999-11-04
RU2224760C2 (ru) 2004-02-27
ES2255754T3 (es) 2006-07-01
MY121864A (en) 2006-02-28
AU743230B2 (en) 2002-01-24
NO20005434L (no) 2000-10-27
NO20005434D0 (no) 2000-10-27
ID27049A (id) 2001-02-22
DE59912986D1 (de) 2006-02-02
HK1037628A1 (en) 2002-02-15

Similar Documents

Publication Publication Date Title
CO5011050A1 (es) Tienopirimidinas
CO4980884A1 (es) Tienopirimidinas
ES2189766T3 (es) Pyrazolo (4,3-d)ipiridmidinas.
DE69226848D1 (de) Lichtemittierende Diode mit verästelter Oberflächenelektrode
AR048282A1 (es) Indol- o - glucosidos sustituidos
FI971486A (fi) Alfa-interferonin stabiilit vesiliuosformulaatiot
DK0934937T3 (da) Azolderivater som superoxidradikalinhibitor
ES2037243T3 (es) Tiazolidindionas como agentes hipoglicemicos y anti-ateroscleroticos.
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
ES2141631T3 (es) Estabilizacion del hidrocloruro de naloxon.
BR0100498A (pt) Cama para pessoas em estado de prostraçãopermanente
KR950701615A (ko) 혈소판 응집 저해작용을 갖는 신규한 화합물(novel compound with plate-let aggregation inhibitor activity)
ITMI960029U1 (it) Composizioni perossidiche con resistenza allo scorch
AR025638A1 (es) Conjugados de glucopiranosidas de 2-(4-hidroxi-fenil)-3-metil-1-/4-(2-amin-1-il-etoxi)-bencil/-1h-indol-5-oles
MX9306035A (es) Nuevas bis-naftalimidas sustituidas en forma asimetrica.
NO922521D0 (no) Piperidinyletanolderivater med terapeutisk virkning
NO920648D0 (no) 4-pyrimidonderivater, deres fremstilling og anvendelse
DE68914653D1 (de) Steigerung der c1-inhibitorkonzentrationen mittels interferon gamma allein oder in kombination mit interleukin-6.
NO924898D0 (no) Polyvinylkloridsammensetninger med hoey overflatespenning
ATE290362T1 (de) Hautfärbemittel enthaltend dihydroxyaceton und einen in position 3 unsubstituierte flavylium- salz verbindung
ES2174669B1 (es) Trisresorciniltriazinas.
ES296444Y (es) Bastidor de tejido con uniones de cuna desmontables entre unos soportes laterales levantados y unos travesanos superior e inferior.
DE69116371D1 (de) Antriebseinheit mit doppelkolben
DE60129600D1 (de) Pleuromutilinderivate mit antimikrobieller wirkung
DE68906965D1 (de) Analgetische phenothiazinderivate.